Saudi Arabia vs Thailand: Access to anti-retroviral drugs, female
Saudi Arabia
91.0%
in 2024
Thailand
90.0%
in 2024
Saudi Arabia rank
25th
Thailand rank
27th
Access to anti-retroviral drugs, female over time
- Saudi Arabia
- Thailand
How they compare
Saudi Arabia currently reports 91.0% against 90.0% in Thailand, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Saudi Arabia ahead.
Saudi Arabia ranks 25th and Thailand ranks 27th of 141 countries.
Across the 3 decades both report, Saudi Arabia averaged higher in 2 and Thailand in 1.
Head to head by decade
| Decade | Saudi Arabia | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 12.2% | 12.1% | Saudi Arabia |
| 2010s | 62.5% | 53.9% | 8.6% | Saudi Arabia |
| 2020s | 83.2% | 83.4% | 0.2% | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Saudi Arabia or Thailand?
- Saudi Arabia, at 91.0% against 90.0% in Thailand as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Saudi Arabia and Thailand?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Thailand?
- 25 years are reported by both, from 2000 to 2024.
- How do Saudi Arabia and Thailand rank globally for access to anti-retroviral drugs, female?
- Saudi Arabia ranks 25th and Thailand ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.